Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  propranolol hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-12 of 12 for your search:
Start Over
A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: V99C1-026, IRB:98-09-09, NCT01298284
Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 20 to 80
Sponsor: Other
Protocol IDs: V101C-016;V102C-094, NCT01970748
ß-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer Recurrence
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: SHEBA-09-6994-OZ-CTIL, NCT00888797
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: AAAI9158, UL1TR000040, NCT01847001
Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: VT1-SYS-601, NCT01857817
Efficacy of Propranolol Treatment to Prevent Melanoma Progression
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: HUG-MEL-BB, NCT01988831
Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: CHUBX 2011/35, NCT02104011
Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 20 to 75
Sponsor: Other
Protocol IDs: 392-22.6.07 / 2358 HMO-CTIL, NCT00502684
Feasibility Study: Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011-0800, NCI-2012-00056, NCT01504126
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and older
Sponsor: Other
Protocol IDs: OSU 13023, NCI-2013-01958, NCT02013492
Use of Propranolol to Reduce FDG Uptake in Brown Adipose Tissue in Pediatric Cancer Patients PET Scans
Phase: No phase specified
Type: Diagnostic, Health services research
Status: Approved-not yet active
Age: 12 to 29
Sponsor: Other
Protocol IDs: 14-0468-F3r, NCT02165683
Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Approved-not yet active
Age: Not specified
Sponsor: Other
Protocol IDs: CHUBX 2013/34, NCT02334930
Start Over